Combined intrastromal injection of amphotericin B and topical fluconazole in the treatment of resistant cases of keratomycosis: a retrospective study

Figures & data

Figure 1 (A) A case in group A before treatment; (B) after treatment.

Figure 2 (A) A case in group B before treatment; (B) after treatment.

Table 1 Demographic and clinical findings and outcome in both groups

Parameters	Group A	Group B
Mean age	49.2±11.64 years	51.2±10.07 years
Sex
Male	26 (63.4%)	16 (59.3%)
Female	15 (36.6%)	11 (40.7%)
Total	41	27
Fungal pathogens
Candida	16 (39%)	15 (55.5%)
Aspergillus niger	6 (14.6%)	–
Aspergillus fumigatus	7 (14%)	4 (14.8%)
Penicillium	4 (9.8%)	–
Alternaria	–	5 (18.5%)
Fusarium	8 (19.5%)	3 (11.1%)
Total	41	27
Healed cases	34 (82.9%)	16 (59.3%)
Recovery period	24±6.42 days	39.66 ±13.6 days